A carregar...
Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease worldwide. Despite its high prevalence and rising incidence, there are currently no specific targeted pharmacotherapies approved by the Food and Drug Administration (FDA) for nonalcoholic steatohepatitis (NASH). Cur...
Na minha lista:
| Publicado no: | J Clin Exp Hepatol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6926203/ https://ncbi.nlm.nih.gov/pubmed/31889754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2019.06.003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|